145 related articles for article (PubMed ID: 16985683)
1. Evolving Role of Pro-PSA as a New Serum Marker for the Early Detection of Prostate Cancer.
Khan MA; Partin AW
Rev Urol; 2002; 4(4):198-200. PubMed ID: 16985683
[No Abstract] [Full Text] [Related]
2. [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].
Haese A; Graefen M; Palisaar J; Huland E; Huland H
Urologe A; 2003 Sep; 42(9):1172-87. PubMed ID: 14504750
[TBL] [Abstract][Full Text] [Related]
3. [Epigenetic markers of early diagnostics of prostate cancer.].
Peshkov MN
Klin Lab Diagn; 2018; 63(10):605-609. PubMed ID: 30768880
[TBL] [Abstract][Full Text] [Related]
4. Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml.
Catalona WJ; Bartsch G; Rittenhouse HG; Evans CL; Linton HJ; Amirkhan A; Horninger W; Klocker H; Mikolajczyk SD
J Urol; 2003 Dec; 170(6 Pt 1):2181-5. PubMed ID: 14634374
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer.
Lieberman R
Am J Ther; 2004; 11(6):501-6. PubMed ID: 15543092
[TBL] [Abstract][Full Text] [Related]
6. A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.
Mikolajczyk SD; Marker KM; Millar LS; Kumar A; Saedi MS; Payne JK; Evans CL; Gasior CL; Linton HJ; Carpenter P; Rittenhouse HG
Cancer Res; 2001 Sep; 61(18):6958-63. PubMed ID: 11559576
[TBL] [Abstract][Full Text] [Related]
7. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
Pannek J; Rittenhouse HG; Evans CL; Finlay JA; Bruzek DJ; Cox JL; Chan DW; Subong EN; Partin AW
Urology; 1997 Nov; 50(5):715-21. PubMed ID: 9372881
[TBL] [Abstract][Full Text] [Related]
8. New serum tests for the diagnosis of prostate cancer.
Haese A; Partin AW
Drugs Today (Barc); 2001 Sep; 37(9):607-616. PubMed ID: 12743632
[TBL] [Abstract][Full Text] [Related]
9. [PSA and hK2 in the diagnosis of prostate cancer].
Alapont Alacreu JM; Navarro Rosales S; Budía Alba A; España Furió F; Morera Martínez F; Jiménez Cruz JF
Actas Urol Esp; 2008 Jun; 32(6):575-88. PubMed ID: 18655340
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
Oesterling JE
J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
[TBL] [Abstract][Full Text] [Related]
11. Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer.
Mikolajczyk SD; Catalona WJ; Evans CL; Linton HJ; Millar LS; Marker KM; Katir D; Amirkhan A; Rittenhouse HG
Clin Chem; 2004 Jun; 50(6):1017-25. PubMed ID: 15054080
[TBL] [Abstract][Full Text] [Related]
12. Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen.
Catalona WJ; Bartsch G; Rittenhouse HG; Evans CL; Linton HJ; Horninger W; Klocker H; Mikolajczyk SD
J Urol; 2004 Jun; 171(6 Pt 1):2239-44. PubMed ID: 15126794
[TBL] [Abstract][Full Text] [Related]
13. [PSA level of the transitional zone: a new marker especially reliable for the detection of prostatic cancer].
Roumeguere T; Zlotta AR; Djavan BR; Marberger M; Schulman CC
Acta Urol Belg; 1997 Mar; 65(1):5-9. PubMed ID: 9245203
[TBL] [Abstract][Full Text] [Related]
14. [Prostate-specific antigen].
Eide IA; Angelsen A
Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2528-31. PubMed ID: 11070990
[TBL] [Abstract][Full Text] [Related]
15. [Use of [-2] pro PSA and phi index for early detection of prostate cancer: a prospective of 452 patients].
Houlgatte A; Vincendeau S; Desfemmes F; Ramirez J; Benoist N; Bensalah K; Durand X
Prog Urol; 2012 May; 22(5):279-83. PubMed ID: 22515924
[TBL] [Abstract][Full Text] [Related]
16. [The usefulness of prostate-specific antigen assay for the early detection and follow up of the prostate cancer].
Saito Y
Nihon Rinsho; 1998 Aug; 56(8):1989-93. PubMed ID: 9750493
[TBL] [Abstract][Full Text] [Related]
17. PSA and other tissue kallikreins for prostate cancer detection.
Stephan C; Jung K; Lein M; Diamandis EP
Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069
[TBL] [Abstract][Full Text] [Related]
18. A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue.
Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Marks LS; Song W; Wheeler TM; Slawin KM
Cancer Res; 2000 Feb; 60(3):756-9. PubMed ID: 10676664
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
Fitzpatrick JM; Banu E; Oudard S
BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
[TBL] [Abstract][Full Text] [Related]
20. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA.
Herwig R; Mitteregger D; Djavan B; Kramer G; Margreiter M; Leers MP; Glodny B; Haider DG; Hörl WH; Marberger M
Eur J Clin Invest; 2008 Jun; 38(6):430-7. PubMed ID: 18489403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
